ADAM10-mediated release of heregulin confers resistance to trastuzumab by activating HER3.
Oncotarget
Ebbing, Eva A EA; Medema, Jan Paul JP; Damhofer, Helene H; Meijer, Sybren L SL; Krishnadath, Kausilia K KK; van Berge Henegouwen, Mark I MI; Bijlsma, Maarten F MF; van Laarhoven, Hanneke W M HW